Clinical Trial Update: Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant study evaluating SHR-A1811 with or without letrozole in early-stage hormone receptor-positive, HER2-low breast cancer; currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• SHR-A1811

Snippet

Sponsor: First Hospital of China Medical University | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING